Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.
Background/Aim: Resistance to metronidazole is one of the most common reasons for Helicobacter pylori treatment failure with the classic triple therapy. The clarithromycin-based regimen is not cost-effective for use in developing countries. Though furazolidone is a great substitute it has many side...
| Publicado en: | Saudi Journal of Gastroenterology Vol. 16; no. 1; pp. 14 - 19 |
|---|---|
| Autores principales: | , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Jan2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |